Diagnostic Tests was Biodesix’s largest product and service line in fiscal 2025, bringing in $79.20M of $88.50M (89%).
| Product and Service | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|
| Diagnostic Tests | $34.54M | — | $64.71M | $79.20M | |||
| Lung Diagnostic Testing | — | $45.19M | — | — | |||
| Development Services | — | $3.90M | $6.62M | $9.30M | |||
| Services | — | — | — | — | |||
| Biopharma Services & Other | $3.67M | — | — | — | |||
| Total | $38.21M | $49.09M | $71.32M | $88.50M |
Biodesix brought in $88.50M from its two product and service lines in fiscal 2025, the year ended December 31, 2025. That was up 24.1% from $71.32M in fiscal 2024. Diagnostic Tests was the largest at $79.20M (89.5%), ahead of Development Services at $9.30M (10.5%).
Compared with fiscal 2024, Development Services grew 40.6% to $9.30M and Diagnostic Tests grew 22.4% to $79.20M.
Biodesix began breaking out Development Services in fiscal 2023, when it brought in $3.90M. Biodesix stopped reporting Lung Diagnostic Testing ($45.19M in fiscal 2023) and Biopharma Services & Other ($3.67M in fiscal 2022) as separate lines.
Biodesix (BDSX) reports its revenue by product and service. In fiscal 2025, Diagnostic Tests was its largest product and service line, bringing in $79.20M (89.5% of the total), followed by Development Services at $9.30M (10.5%).
Diagnostic Tests was Biodesix's largest product and service line in fiscal 2025, bringing in $79.20M, or 89.5% of the $88.50M total across its two product and service lines.
Development Services grew faster than Diagnostic Tests in fiscal 2025, up 40.6% from $6.62M to $9.30M. Diagnostic Tests grew 22.4% to $79.20M.
Every figure comes from Biodesix's annual financial filings, as reported. Each line keeps the name Biodesix gives it, and years follow its fiscal calendar.
Biodesix's revenue by product and service goes back to fiscal 2019, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.